NEW YORK, Dec. 8 Reportlinker.com announces that a new market research report is available in its catalogue: Pharmacodynamic Assays http:www.reportlinker.com/p0167260/Pharmacodynamic-Assays.html Pharmacodynamic assays are ...
MORRISTOWN, N.J., Dec. 8 In consultation with the U.S. Food and Drug Administration (FDA), Bayer's Consumer Care division has begun a voluntary recall of a single product lot of the combination package of Alka-Seltzer Plus® Day & Night Cold Formula ...
Emerging Hepatitis C Virus Therapies in Brazil Will Reach Combined Sales of Nearly $15 Million by 2013, According to a New Report from Decision Resources For more information, contact: Gisselle Morales Elizabeth ...
CONTACT: Jerome Lyons, Office Manager T: 206.826.9900 [email protected] ...
Scientific Advancement and Culture of Wellness Converge to Drive Booming New Market NEW YORK , Dec. 8 -- The market for personalized medicine in the United States is already $232 billion , and it is projected to grow 11 percent ...
Dapagliflozin, a medication prescribed for managing Type 2 diabetes , has demonstrated additional benefits in heart failure conditions. This drug lowers the likelihood of hospitalization due to heart failure and mortality in ...
The efficacy of mRNA vaccine technology demonstrated during the COVID-19 pandemic provides optimism for its utilization in mitigating preventable illnesses across various disease domains ( ). ...
An intradermal monkeypox (Mpox) vaccination regimen with reduced dosage proved safe and elicited an antibody response comparable to the standard regimen at six weeks (two weeks post-second dose). ...
The World Health Organization (WHO) granted prequalification to a novel oral cholera vaccine on April 12. The Euvichol-S oral vaccine, which is inactivated, demonstrates comparable effectiveness to the current vaccines, ...
Alectinib, a molecule developed by Genentech, Inc has been granted approval by the Food and Drug Administration on April 18, 2024, for the adjuvant treatment of patients with anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer ...
Subscribe to our Free Newsletters!
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2024
Careers